Acorda Therapeutics, Inc. is an American biotechnology company based in New York and founded in 1995 by Ron Cohen that develops therapies that improve neurological function in people and manufactures and markets the drugs Inbrija and Ampyra.
Acorda Therapeutics, Inc. is an American biotechnology company based in Ardsley, New York. 1995; 25 years ago (1995) Ron Cohen The company develops therapies that improve neurological function in people with Parkinson's disease, multiple sclerosis and other neurological disorders. Acorda Therapeutics manufactures and markets the drugs Inbrija (levodopa inhalation powder) and Ampyra (dalfampridine) in the United States. 
